Dr. Ongchin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UPMC Passavant
9100 Babcock Blvd, Ground fl
Pittsburgh, PA 15237Phone+1 412-748-3254
Summary
- Dr. Melanie Ongchin is a surgical oncologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Presbyterian, UPMC Passavant, UPMC Presbyterian Shadyside - Shadyside. She received her medical degree from Rutgers New Jersey Medical School and has been in practice 10 years. She specializes in surgical oncology (other than breast) and is experienced in biliary tract disease, pancreatic disease, malignant melanoma, surgical oncology (non-breast), and sarcomas.
Education & Training
- UPMC Medical EducationFellowship, Complex General Surgical Oncology, 2012 - 2014
- University at BuffaloResidency, Surgery, 2006 - 2012
- Rutgers New Jersey Medical SchoolClass of 2006
Certifications & Licensure
- PA State Medical License 2012 - 2024
- NY State Medical License 2014 - 2020
- NJ State Medical License 2017 - 2019
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 75 citationsNon-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and ...Wenzel M. Hackeng, Lodewijk A.A. Brosens, Joo Young Kim, Roderick J. O’Sullivan, You Na Sung
Gut. 2021-04-13 - 57 citationsProspective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Managemen...Alessandro Paniccia, Patricio M Polanco, Brian A Boone, Abigail I Wald, Kevin McGrath
Gastroenterology. 2023-01-01 - 17 citationsKRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapyLaura A. Favazza, Christine Megerdichian Parseghian, Cihan Kaya, Marina N. Nikiforova, Somak Roy
Modern Pathology. 2020-05-06
Press Mentions
- Cancer Care – Close to HomeDecember 21st, 2020
- Taking Liver Cancer Surgery to New LevelsNovember 9th, 2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: